Get notified when HNGE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsrevenue $182.3M, net income $35.1M. Hinge Health debuts with 47% revenue growth, 85% margins, and in buybacks
Filed May 7, 2026 · Period ending March 31, 2026 · ~1 min read
Key Changes
-
high
Revenue surged 47% YoY to $182M in Q1 2026, driven by existing client expansion. Gross margin improved to 85% (up 4 points) through care team and supply chain efficiencies. Net income more than doubled to $35M.
MD&A: Financial Results verify on EDGAR → -
high
Free cash flow jumped from $4M to $42M (23% margin), enabling $105M in share repurchases under a new up to $250M program. Company maintains $406M in cash and marketable securities.
MD&A: Cash Flow & Capital Allocation verify on EDGAR → -
high
Three health plan partners (HCSC, Elevance, Aetna) represent ~40% of revenue; 84% of total revenue flows through partner relationships. Loss of any major partner would materially impact results.
Risk Factors: Client Concentration verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (P 10-Q) is open in full — no account needed.
Partner
Trade HNGE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 10, 2026 · How we verify